Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AST-001 in Children with Autism Spectrum Disorder (Phase III, Double-blind, Placebo-controlled, with Open-label Extension)
KCT0008915Phase 3Completed
- Sponsor
- Astrogen
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Threonine in Autism Spectrum Disorder (ASD), sponsored by Astrogen. Started Aug 2023; status: completed.
02
Drugs
Threonine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on KCT0008915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008915.